KYMERA THERAPEUTICS I
43.54
08-أكتوبر-24 12:32:21
15 متأخرة بدقائق
الأسهم
+1.33
+3.15%
نطاق اليوم
42.41 - 43.62
ISIN
N/A
المصدر
NASDAQ
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
28 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Business Update
03 أغسطس 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Second Quarter 2023 Financial Results on August 3
27 يوليو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
22 يونيو 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
14 يونيو 2023 02:30:00 بحسب Nasdaq GlobeNewswire
-
09 يونيو 2023 18:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming June Investor Conference
01 يونيو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer
22 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics Doses First Patient in Phase 1 Oncology Trial of MDM2 Degrader KT-253
19 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
18 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update
04 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report First Quarter 2023 Financial Results on May 4
11 أبريل 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
01 مارس 2023 07:00:02 بحسب Nasdaq GlobeNewswire
-
23 فبراير 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 23
01 فبراير 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
10 يناير 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary
04 يناير 2023 07:00:02 بحسب Nasdaq GlobeNewswire
-
03 يناير 2023 07:00:00 بحسب Nasdaq GlobeNewswire